Problematic and injecting drug use findings from the harm reduction database hrd
This presentation is the property of its rightful owner.
Sponsored Links
1 / 12

Problematic and injecting drug use – findings from the Harm Reduction Database (HRD) PowerPoint PPT Presentation


  • 38 Views
  • Uploaded on
  • Presentation posted in: General

Problematic and injecting drug use – findings from the Harm Reduction Database (HRD). Presenter: Josie Smith, Health Protection, PHW. Estimates of problematic and injecting drug use. EMCDDA

Download Presentation

Problematic and injecting drug use – findings from the Harm Reduction Database (HRD)

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Problematic and injecting drug use findings from the harm reduction database hrd

Problematic and injecting drug use – findings from the Harm Reduction Database (HRD)

Presenter: Josie Smith, Health Protection, PHW


Estimates of problematic and injecting drug use

Estimates of problematic and injecting drug use

EMCDDA

  • Problematic drug use – “injecting drug use or long duration or regular use of opioids, cocaine and/or amphetamines”

  • UK estimates indicate around 1% or 10 per 1000 population aged 15 – 64 years

  • Translates to around 20,000 individuals in Wales

  • Injecting drug use – UK estimates indicate around 0.4% of population aged 15 – 64 years

  • Translates to around 8,000 individuals in Wales


Wales hrd data 1 09 10 31 03 11

Wales HRD data 1/09/10 – 31/03/11

7277 individuals registered with needle exchange

  • Female – 1004 (14%)

  • Male – 6273 (86%)

    Would expect:

    25% female

    75% male

    Pharmacy?

  • What is the extent of secondary / peer distribution?


Profile of service provision 2011

Profile of service provision 2011


Number of individuals registered

Number of individuals registered


Wales data age profile by gender data from all sites activity 01 09 10 to 31 03 11

Wales data – Age profile by genderData from all sites: Activity 01/09/10 to 31/03/11


Profile of substances used by apb

Profile of substances used by APB


Details available for analysis

Details available for analysis

  • Age

  • Gender

  • Year of first injecting

  • Area of residence

  • Housing status

  • Substances used

  • Blood borne virus monitoring

  • Injecting equipment reuse and sharing behaviour


Uses of data reporting mechanisms

Uses of data / reporting mechanisms

  • Provider activity data

    • Planning of opening times, additional services for young people, females, steroid users

    • Address additional health / other needs

    • Address specific risk behaviours with service users

  • Local planning (APB/CSP/SMARTs)

    • Coverage

    • Quality

    • Nature of local injecting (and wider problematic drug use) behaviours

  • National planning (WAG, Public Health)


Next steps improving data quality

Next steps: Improving data quality

  • Some services completing client details

  • Other services completing bare minimum - visits to sites reinforcing need to complete client details/assessment in order to provide quality service


Next steps rolling out to pharmacy

Next steps : rolling out to pharmacy

  • Working in conjunction with Pharmacy WAG to implement in existing community pharmacy services across Wales (2011)

  • Addition of take home Naloxone section – stat and voluntary sector


Problematic and injecting drug use findings from the harm reduction database hrd

All service users and staff from voluntary and statutory services

Regional co-ordinators

WAG

Public Health

Thank you!


  • Login